These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30572481)

  • 1. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
    Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
    Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
    Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
    Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of small cell lung cancer patients with diabetes treated with metformin.
    Xu T; Liang G; Yang L; Zhang F
    Clin Transl Oncol; 2015 Oct; 17(10):819-24. PubMed ID: 26063645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
    Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
    BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
    Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
    Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
    Zeng S; Gan HX; Xu JX; Liu JY
    Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure.
    Yoshida T; Kuroda H; Oya Y; Shimizu J; Horio Y; Sakao Y; Hida T; Yatabe Y
    Lung Cancer; 2017 Jul; 109():89-91. PubMed ID: 28577956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
    Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
    Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
    Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
    Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of metformin for non-small cell lung cancer patients with diabetes.
    Xu T; Li D; He Y; Zhang F; Qiao M; Chen Y
    World J Surg Oncol; 2018 Mar; 16(1):60. PubMed ID: 29558957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
    Du G; Yang Y; Zhang Y; Sun T; Liu W; Wang Y; Li J; Zhang H
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):893-904. PubMed ID: 23355038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with stage IV lung cancer with diabetes treated with metformin.
    Lin JJ; Gallagher EJ; Sigel K; Mhango G; Galsky MD; Smith CB; LeRoith D; Wisnivesky JP
    Am J Respir Crit Care Med; 2015 Feb; 191(4):448-54. PubMed ID: 25522257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus.
    Zeng X; Xu C; Cheng J; Sun C; Wang Z; Gong Z; Long H; Zhu B
    Cancer Med; 2020 Feb; 9(3):902-911. PubMed ID: 31830375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Park TS; Kim HR; Koh JS; Jang SH; Hwang YI; Yoon HI; Chung JH; Kim CH; Kim SS; Kim WS; Jo J; Lee JC; Choi CM
    Lung Cancer; 2014 Nov; 86(2):262-7. PubMed ID: 25261232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
    Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
    Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
    J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
    Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
    Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.